Literature DB >> 6357936

Effects of propranolol on renal blood flow and renal function in patients with cirrhosis.

C Bataille, E Bercoff, E A Pariente, D Valla, D Lebrec.   

Abstract

Systemic and splanchnic hemodynamics, renal blood flow, and renal function were studied in 13 patients with cirrhosis both before and 1 h after oral administration of 40 mg of propranolol (acute administration) and 1 mo after continuous administration of this substance at doses reducing the heart rate by 25% (chronic administration). Cardiac output and the gradient between wedged and free hepatic venous pressures significantly decreased after acute and chronic administration of propranolol; mean arterial pressure did not change significantly and systemic vascular resistance significantly increased. Renal blood flow and renal vascular resistance did not change significantly after acute administration of propranolol and renal function did not change significantly after acute or chronic administration of propranolol. We conclude that propranolol does not alter renal function in patients with cirrhosis who are in good physical condition.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6357936

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  6 in total

Review 1.  The medical prevention of variceal bleeding.

Authors:  D Lebrec
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

2.  Acute effect of propranolol and isosorbide-5-mononitrate administration on renal blood flow in cirrhotic patients.

Authors:  A J Stanley; I A Bouchier; P C Hayes
Journal:  Gut       Date:  1998-02       Impact factor: 23.059

3.  Prophylaxis of first variceal hemorrhage in patients with liver cirrhosis.

Authors:  T Sauerbruch; G Kleber; A Gerbes; G Paumgartner
Journal:  Klin Wochenschr       Date:  1986-12-15

4.  Effect of propranolol on urinary prostaglandin E2 excretion and renal interlobar arterial blood flow after furosemide administration in patients with hepatic cirrhosis.

Authors:  N Ljubicić; A Bilić; V Plavsić
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

5.  A randomised controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis.

Authors:  D Lebrec; T Poynard; J Bernuau; E Bercoff; O Nouel; J P Capron; R Poupon; M Bouvry; B Rueff; J P Benhamou
Journal:  Drugs       Date:  1989       Impact factor: 9.546

6.  Impact of Propranolol on Preventing Renal Dysfunction in Patients with Cirrhosis.

Authors:  Kambiz Akhavan Rezayat; Abbas Ali Zeraati; Masoud Pezeshki Rad; Jalal Chogan; Najmeh Davoudian; Amir Akhavan Rezayat; Seyed Mousalreza Hoseini
Journal:  Middle East J Dig Dis       Date:  2017-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.